Retirement Planning Company of New England’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Hold
1,356
0.08% 250
2026
Q1
$207K Buy
+1,356
New +$208K 0.08% 232
2023
Q3
Sell
-2,695
Closed -$272K 225
2023
Q2
$272K Sell
2,695
-46
-2% -$4.6K 0.16% 170
2023
Q1
$252K Buy
2,741
+19
+0.7% +$1.66K 0.15% 176
2022
Q4
$247K Sell
2,722
-8
-0.3% -$674 0.16% 176
2022
Q3
$207K Hold
2,730
0.15% 187
2022
Q2
$230K Buy
2,730
+5
+0.2% +$439 0.16% 180
2022
Q1
$239K Buy
2,725
+94
+4% +$8.14K 0.14% 197
2021
Q4
$230K Buy
+2,631
New +$218K 0.11% 194

Other funds holding NVS

Retirement Planning Company of New England's NVS Position: Q2 2026 in Review

Retirement Planning Company of New England held its Novartis (NVS) position steady in Q2 2026 at 1,356 shares worth $213K. The position accounts for 0.08% of the portfolio, ranked #250.

Retirement Planning Company of New England first reported a position in NVS in Q4 2021 and has held it in 9 quarters since. The position peaked at $272K in Q2 2023. 1,613 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Retirement Planning Company of New England held 1,356 shares of Novartis worth $213K as of Q2 2026.
  • Retirement Planning Company of New England left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.08% of Retirement Planning Company of New England's portfolio in Q2 2026, its #250 holding.
  • Retirement Planning Company of New England first reported a position in Novartis in Q4 2021 and has held it in 9 quarters since.
  • Retirement Planning Company of New England's Novartis position peaked at $272K in Q2 2023.
  • 1,613 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.